 |
|
written by Anatole A. Klyosov, Igor L. Rozhanskii,
published by Journal of Cancer Therapy, Vol.8 No.2, 2017
has been cited by the following article(s)：
-
[1] The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
Cell Death & Disease 2017[2] Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
2018[3] The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
2018 - No relevant information.